Workflow
宏利金融-S(00945) - 2022 Q3 - 季度财报
00945MANULIFE(00945)2022-11-10 00:08

Financial Performance - Manulife reported a net income attributable to shareholders of CAD 1.3 billion for Q3 2022, a decrease of CAD 200 million compared to Q3 2021[1]. - Core earnings for Q3 2022 were CAD 1.3 billion, representing a 14% decrease year-over-year on a constant currency basis[1]. - Net income attributable to shareholders for Q3 2022 was CAD 1.347 billion, down from CAD 1.592 billion in Q3 2021, reflecting a decrease of 15.4%[9]. - Core earnings for Q3 2022 were CAD 1.322 billion, a decline of 14% compared to CAD 1.517 billion in Q3 2021[10]. - The return on common equity for Q3 2022 was 10.5%, down from 12.6% in Q3 2021[9]. - The expense ratio for Q3 2022 was 53.9%, compared to 51.3% in Q3 2021, indicating increased operational costs[9]. - Core earnings (after tax) for the company reached CAD 4,828 million, reflecting a 68% increase compared to the previous year[36]. - The net income attributable to shareholders (after tax) was CAD 5,021 million, with a significant contribution from Asia at CAD 2,412 million[35]. Sales and Business Value - The annualized premium equivalent sales for Q3 2022 were CAD 1.3 billion, down 6% from Q3 2021[2]. - The new business value for Q3 2022 was CAD 514 million, a decrease of 6% compared to the same quarter in 2021[2]. - New business value in Asia dropped by 17% year-over-year, primarily due to lower sales in Hong Kong[12]. - New business value in Canada increased by 25% year-over-year, driven by improved margins in the insurance business[12]. - New business value in the U.S. rose by 27% year-over-year, attributed to pricing measures and rising interest rates[12]. - The sales of products featuring Vitality PLUS increased by 12% compared to Q3 2021, indicating growing interest among health-conscious consumers[13]. Wealth and Asset Management - Global wealth and asset management business recorded net inflows of CAD 3 billion in Q3 2022, down from CAD 9.8 billion in Q3 2021[2]. - The total assets under management in the global wealth and asset management business were CAD 748.8 billion, down from CAD 823.6 billion[9]. - The total investment assets managed by the Global Wealth and Asset Management business as of September 30, 2022, were 411,292million,anincreasefrom411,292 million, an increase from 402,329 million on June 30, 2022, representing a growth of 2.4%[40]. - The total assets under administration provided by the Global Wealth and Asset Management division amounted to 855.9billion,a5.9855.9 billion, a 5.9% increase from the previous quarter[41]. Operational Efficiency - The core EBITDA for Q3 2022 was 504 million, reflecting a 7.9% increase compared to 467millioninQ22022[43].ThecoreEBITDAmarginimprovedto32.7467 million in Q2 2022[43]. - The core EBITDA margin improved to 32.7% in Q3 2022, up from 30.7% in Q2 2022[43]. - The efficiency ratio for Q3 2022 was 53.9%, compared to 49.2% in Q2 2022, indicating increased operational costs relative to earnings[44]. - Core general expenses for Q3 2022 were 1.859 billion, slightly higher than $1.843 billion in Q2 2022[44]. Strategic Initiatives - Manulife expanded its Manulife Vitality program to include new policyholders for term and universal life insurance starting November 2022[4]. - The company introduced advanced early detection services for multiple cancers through the Galleri® test, becoming the first life insurer to offer this service[5]. - The company plans to continue expanding its market presence and investing in new technologies to enhance service offerings[41]. Risks and Uncertainties - The company emphasizes that forward-looking statements are subject to risks and uncertainties, and actual performance may differ significantly from expectations[46]. - Significant factors affecting actual performance include general business and economic conditions, market volatility, interest rates, and credit spreads[47]. - The ongoing impact of the COVID-19 pandemic, including any variants, poses additional risks to the company's performance[47]. - Legal and regulatory changes may affect the company's operations and financial performance[47]. - The company acknowledges the challenges in attracting and retaining key personnel, which could impact operational effectiveness[48].